Underwriting Guidance, COVID-19

Ameritas Life Insurance Corp. continues to evaluate and adjust our underwriting practices to support your business and navigate the risks associated with the ongoing COVID-19 pandemic. As a result of our evaluation, temporary guidelines originally announced on April 13, 2020 have been reviewed and updated on an ongoing basis. Please review the guidelines carefully to ensure you are familiar with the updates, including the most recent addition of 30 day parameters to the amendment regarding COVID exposure and diagnosis, and specific guidelines for the survivor product.